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Recently Sara Crespo Yanguas and colleagues from the University of Brussel published a study about the role of pannexin1 in the pathogenesis of liver fibrosis (Crespo Yanguas et al., 2018\[[@R3]\]). Panx channels are known as mediators of ATP release (Dahl, 2015\[[@R4]\]). After injury cells may release ATP and uridine-5\'-triphosphate into the extracellular space. The released ATP attracts immune cells to the area of damage (Davalos et al., 2005\[[@R5]\]; Chekeni et al., 2010\[[@R2]\]). In cardiac fibrosis cardiomyocytes have been shown to release ATP via pannexin1 which contributes to activation of fibroblasts (Dolmatova et al., 2012\[[@R6]\]). However, in liver the role of pannexin1 in liver fibrosis remains unknown. Therefore, the authors compared pannexin1 knockout and wild-type mice after CCl~4~ treatment for 8 weeks and after bile duct ligation (Crespo Yanguas et al., 2018\[[@R3]\]).

Interestingly, pannexin1 knockout mice showed reduced collagen content, stellate cell activation, and inflammation compared to wild-type mice. Therefore, the release of ATP seems to contribute to myofibroblast activation also in the liver. In contrast to the CCl~4~- fibrosis model, bile duct ligation led to more hepatocellular injury and a stronger immune response in the pannexin1 knockout than in wild-type mice.

It is not surprising that different consequences are observed in the CCl~4~ and the bile duct ligation models. CCl~4~ is a model of pericentral liver damage where a fraction of approximately 40 % of hepatocytes in the centre of the lobule are killed (Hoehme et al., 2010\[[@R16]\]; Hammad et al., 2017\[[@R14]\]; Bartl et al., 2015\[[@R1]\]). It seems plausible that the ATP released from these damaged hepatocytes activates stellate cells (Leist et al., 2017\[[@R18]\]). In contrast, bile duct ligation leads to a ductular response with proliferation of cholangiocytes, branching and looping of bile ducts, leading to a denser mesh of interlobular bile ducts around portal veins (Vartak et al., 2016\[[@R21]\]; Jansen et al., 2017\[[@R17]\]). Simultaneously, periportal fibrosis occurs (Ghallab et al., 2018\[[@R10]\]). It is interesting that this phenomenon is enhanced by the pannexin1 knockout, although the responsible mechanism still has to be elucidated.

Currently, hepatotoxicity *in vivo* (Stöber, 2016\[[@R20]\]; Du et al., 2017\[[@R7]\]; Reif et al., 2017\[[@R19]\]; Hammad et al., 2018\[[@R15]\]; Ghallab et al., 2016\[[@R9]\]) as well as mechanistic studies in hepatocyte *in vitro* systems represent very active research areas (Ghallab, 2017\[[@R8]\]; Godoy et al., 2013\[[@R11]\], 2015\[[@R12]\], 2016\[[@R13]\]). In this rapidly progressing field Sara Crespo Yanguas and colleagues made an important contribution by revealing the role of ATP-release channels in the pathogenesis of liver fibrosis.
